Lorazepam Supplier-Buyer Network — Trade Flow Analysis

Name: Lorazepam Supplier-Buyer Trade Network Dataset — 24+ Indian Exporters, 11+ Importers, 21+ Countries (DGFT 2022–2026)
Creator: TransData Nexus
License: https://transdatanexus.com/terms
Keywords: Lorazepam supplier network, Lorazepam buyers, pharmaceutical export India, Lorazepam trade data

TransData Nexus

Lorazepam

India Pharmaceutical Trade Intelligence

$2.5M24 Suppliers21 CountriesHS 30049099

ExportsIndia → UNITED STATES45.6%India → SRI LANKA13.4%

ImportsUNITED STATES → India$34.1K GERMANY → India$26.3K

#1 Supplier: APL HEALTHCARE #1 Buyer: XXROBXXDO XXARMXXUSAXX

Who Supplies Lorazepam? Top Manufacturers & Buyers 2026 — APL HEALTHCARE LIMITED Leads | TransData Nexus | TransData Nexus

1APL HEALTHCARE LIMITED

APL HEALTHCARE LIMITED is the first-largest Lorazepam exporter from India, with a market share of 37.7% and a total export value of $947.1K across 19 shipments. Their average shipment value of $49.8K is above the market average of $20.1K, suggesting premium or bulk contract pricing.

APL HEALTHCARE LIMITED serves 3 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• XXROBXXDO XXARMXXUSAXX INXX — $454.5K across 9 shipments (48.0% of this supplier's total exports)

• AUROBINDO PHARMA USA INC — $427.0K across 9 shipments (45.1% of this supplier's total exports)

• XXROBXXDO XXARMXXUSAXX INXX — $65.6K across 1 shipments (6.9% of this supplier's total exports)

Key Insight: APL HEALTHCARE LIMITED's per-shipment value of $49.8K is 148% above the market average of $20.1K, consistent with large-order contracts or value-added formulations.

2CENTAUR PHARMACEUTICALS PRIVATE LIMITED

CENTAUR PHARMACEUTICALS PRIVATE LIMITED is the second-largest Lorazepam exporter from India, with a market share of 17.5% and a total export value of $439.8K across 30 shipments. Their average shipment value of $14.7K is below the market average of $20.1K, reflecting a high-volume, competitive pricing strategy.

CENTAUR PHARMACEUTICALS PRIVATE LIMITED serves 5 named buyers in our database. ORION CORPORATION is the dominant customer, accounting for 54.0% of this supplier's tracked business. Top customers include:

• ORION CORPORATION — $237.4K across 16 shipments (54.0% of this supplier's total exports)

• SPIRIG HEALTHCARE AG — $132.8K across 9 shipments (30.2% of this supplier's total exports)

• RIVOPHARM UK LTD C/O — $45.7K across 3 shipments (10.4% of this supplier's total exports)

• ORION CORPORATION — $21.8K across 1 shipments (5.0% of this supplier's total exports)

• CORPORACION FARMACEU — $2.1K across 0 shipments (0.5% of this supplier's total exports)

Key Insight: CENTAUR PHARMACEUTICALS PRIVATE LIMITED operates with high shipment frequency (30 shipments) at a per-shipment value of $14.7K, indicating a broad distribution network with many smaller, regular orders.

3VENOR PHARMA LIMITED

VENOR PHARMA LIMITED is the third-largest Lorazepam exporter from India, with a market share of 9.0% and a total export value of $227.2K across 3 shipments. Their average shipment value of $75.7K is above the market average of $20.1K, suggesting premium or bulk contract pricing.

VENOR PHARMA LIMITED serves 2 named buyers in our database. STATE PHARMACEUTICAL is the dominant customer, accounting for 99.0% of this supplier's tracked business. Top customers include:

• STATE PHARMACEUTICAL — $224.8K across 3 shipments (99.0% of this supplier's total exports)

• TO THE ORDER OF — $2.3K across 0 shipments (1.0% of this supplier's total exports)

Key Insight: VENOR PHARMA LIMITED's per-shipment value of $75.7K is 277% above the market average of $20.1K, consistent with large-order contracts or value-added formulations.

4ESJAY PHARMA PRIVATE LIMITED

ESJAY PHARMA PRIVATE LIMITED is the fourth-largest Lorazepam exporter from India, with a market share of 8.0% and a total export value of $200.0K across 4 shipments. Their average shipment value of $50.0K is above the market average of $20.1K, suggesting premium or bulk contract pricing.

ESJAY PHARMA PRIVATE LIMITED serves 2 named buyers in our database. ANIP ACQUISTION COMPANY is the dominant customer, accounting for 66.6% of this supplier's tracked business. Top customers include:

• ANIP ACQUISTION COMPANY — $133.3K across 3 shipments (66.6% of this supplier's total exports)

• THE PURCHASE MANAGER — $66.7K across 1 shipments (33.4% of this supplier's total exports)

Key Insight: ESJAY PHARMA PRIVATE LIMITED's per-shipment value of $50.0K is 149% above the market average of $20.1K, consistent with large-order contracts or value-added formulations.

5J B CHEMICALS PHARMACEUTICALS LIMITED

J B CHEMICALS PHARMACEUTICALS LIMITED is the fifth-largest Lorazepam exporter from India, with a market share of 5.3% and a total export value of $133.9K across 5 shipments. Their average shipment value of $26.8K is above the market average of $20.1K, suggesting premium or bulk contract pricing.

J B CHEMICALS PHARMACEUTICALS LIMITED serves 1 named buyer in our database. GENESIS PHARMACEUTICALS LIMITED. is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:

• GENESIS PHARMACEUTICALS LIMITED. — $133.9K across 5 shipments (100.0% of this supplier's total exports)

Key Insight: J B CHEMICALS PHARMACEUTICALS LIMITED's per-shipment value of $26.8K is 33% above the market average of $20.1K, consistent with large-order contracts or value-added formulations.

6J B CHEMICALS AND PHARMACEUTICALS LIMITED

J B CHEMICALS AND PHARMACEUTICALS LIMITED is the fifth-largest Lorazepam exporter from India, with a market share of 5.1% and a total export value of $127.4K across 19 shipments. Their average shipment value of $6.7K is below the market average of $20.1K, reflecting a high-volume, competitive pricing strategy.

J B CHEMICALS AND PHARMACEUTICALS LIMITED serves 3 named buyers in our database. GENESIS PHARMACEUTICALS LIMITED. is the dominant customer, accounting for 89.2% of this supplier's tracked business. Top customers include:

• GENESIS PHARMACEUTICALS LIMITED. — $113.7K across 17 shipments (89.2% of this supplier's total exports)

• GENESIS PHARMACEUTICALS LIMITED. — $13.7K across 2 shipments (10.8% of this supplier's total exports)

• SYNERGY HEALTH UTREC — $0 across 0 shipments (0.0% of this supplier's total exports)

Key Insight: J B CHEMICALS AND PHARMACEUTICALS LIMITED operates with high shipment frequency (19 shipments) at a per-shipment value of $6.7K, indicating a broad distribution network with many smaller, regular orders.

1United States

United States ranks as the first-largest destination for Lorazepam imports from India, with a total trade value of $1.1M across 22 shipments — representing a 45.6% share of all Lorazepam exports. The average shipment value of $52.1K is above the global average of $20.1K, indicating high-value procurement contracts or branded formulations. This market is served by 4 tracked buyers.

Named Lorazepam importers in United States: XXROBXXDO XXARMXXUSAXX INXX is the largest buyer, accounting for 39.6% ($454.5K) of this market's total imports.

• XXROBXXDO XXARMXXUSAXX INXX — $454.5K (39.6% of United States's total)

• AUROBINDO PHARMA USA INC — $427.0K (37.2% of United States's total)

• ANIP ACQUISTION COMPANY — $133.3K (11.6% of United States's total)

Key Insight: United States's per-shipment average of $52.1K (159% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

United States is a key market for Lorazepam imports from India.

Primary Market

Secondary Market

2Sri Lanka

Sri Lanka ranks as the second-largest destination for Lorazepam imports from India, with a total trade value of $337.2K across 0 shipments — representing a 13.4% share of all Lorazepam exports. The average shipment value of $337.2K is above the global average of $20.1K, indicating high-value procurement contracts or branded formulations.

Key Insight: Sri Lanka's per-shipment average of $337.2K (1576% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Sri Lanka is a key market for Lorazepam imports from India.

Primary Market

Secondary Market

3United Kingdom

United Kingdom ranks as the third-largest destination for Lorazepam imports from India, with a total trade value of $336.0K across 20 shipments — representing a 13.4% share of all Lorazepam exports. The average shipment value of $16.8K is below the global average of $20.1K, consistent with generic/API volume purchasing. This market is served by 2 tracked buyers.

Named Lorazepam importers in United Kingdom: GENESIS PHARMACEUTICALS LIMITED is the largest buyer, accounting for 52.5% ($176.4K) of this market's total imports.

• GENESIS PHARMACEUTICALS LIMITED — $176.4K (52.5% of United Kingdom's total)

• GENESIS PHARMACEUTICALS LIMITED. — $113.7K (33.8% of United Kingdom's total)

Key Insight: United Kingdom receives frequent, smaller shipments of Lorazepam — typical of markets with distributed retail pharmacy or hospital networks sourcing generics at volume.

United Kingdom is a key market for Lorazepam imports from India.

Primary Market

Secondary Market

4Finland

Finland ranks as the fourth-largest destination for Lorazepam imports from India, with a total trade value of $282.4K across 16 shipments — representing a 11.2% share of all Lorazepam exports. The average shipment value of $17.6K is below the global average of $20.1K, consistent with generic/API volume purchasing. This market is served by 2 tracked buyers.

Named Lorazepam importers in Finland: ORION CORPORATION is the largest buyer, accounting for 92.3% ($260.6K) of this market's total imports.

• ORION CORPORATION — $260.6K (92.3% of Finland's total)

• ORION CORPORATION, — $21.8K (7.7% of Finland's total)

Key Insight: Finland receives frequent, smaller shipments of Lorazepam — typical of markets with distributed retail pharmacy or hospital networks sourcing generics at volume.

Finland is a key market for Lorazepam imports from India.

Primary Market

Secondary Market

5Switzerland

Switzerland ranks as the fifth-largest destination for Lorazepam imports from India, with a total trade value of $132.8K across 4 shipments — representing a 5.3% share of all Lorazepam exports. The average shipment value of $33.2K is above the global average of $20.1K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Lorazepam importers in Switzerland: SPIRIG HEALTHCARE AG is the largest buyer, accounting for 100.0% ($132.8K) of this market's total imports.

• SPIRIG HEALTHCARE AG — $132.8K (100.0% of Switzerland's total)

Key Insight: Switzerland's per-shipment average of $33.2K (65% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Switzerland is a key market for Lorazepam imports from India.

Primary Market

Secondary Market

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Lorazepam.
2.Flow Mapping: 24 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
3.Value Aggregation: Trade value per supplier-buyer link aggregated from 125 individual shipment records. Values are FOB in USD.
4.Geographic Clustering: Buyer networks clustered across 21 destination countries to identify geographic concentration patterns.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

125 Verified Shipments

24 manufacturers in network

Expert-Reviewed

By pharmaceutical trade specialists

Lorazepam

Lorazepam

Who Supplies Lorazepam? Top Manufacturers & Their Global Buyers

🏭 Market Analysis: Top Suppliers & Customer Networks

Market Intelligence

Official References & Regulatory Resources

Who Supplies Lorazepam? Top Manufacturers & Their Buyers

Supplier-Customer Network Analysis

Lorazepam Supplier Network — Key Market Intelligence

Market Analysis: Top Suppliers & Their Customer Networks

1APL HEALTHCARE LIMITED

2CENTAUR PHARMACEUTICALS PRIVATE LIMITED

3VENOR PHARMA LIMITED

4ESJAY PHARMA PRIVATE LIMITED

5J B CHEMICALS PHARMACEUTICALS LIMITED

6J B CHEMICALS AND PHARMACEUTICALS LIMITED

From Indian Factories to Global Pharmacies — How Lorazepam Flows

🌍 Market Analysis: Top Importing Countries & Importers

Where Does Lorazepam Go? Top Importing Countries & Their Buyers

Geographic Market Flow Analysis

Market Analysis: Top Importing Countries & Their Importers

1United States

2Sri Lanka

3United Kingdom

4Finland

5Switzerland

People Also Ask — Lorazepam Supplier & Trade Network

Lorazepam Trade Network — Key Takeaways

Network Overview

Supplier Network

Country Network

Network Insights

Related Analysis

Network Intelligence

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology